Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

NCT00249483 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cocaine-Related Disorders

Interventions

DRUG: Venlafaxine
DRUG: Placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]